Extracellular Vesicles Isolated from Curcumin-medium Weakened RKO Cell Proliferation and Migration

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2024 Jul 11

PMID 38988906

Authors

ChunYan Xu

Chengxia Liu

Affiliations

Soon will be listed here.

Abstract

Background: Curcumin (Cur) is a natural phytochemical that is expected to become an indispensable drug for the treatment of colorectal cancer. A comprehensive understanding of the anti-tumor mechanism of Cur will provide a better reference for its clinical application. This study aimed to examine the effects of extracellular vesicles (EVs) isolated from Cur-medium on RKO colorectal cancer cell proliferation, apoptosis, and migration.

Methods: RKO cells were cultured in various concentrations of Cur-medium, and the EVs were isolated from the Cur-medium. The EVs were identified by transmission electron microscopy and western blotting. The effects of the EVs on RKO cell proliferation, apoptosis, and migration were analyzed, as was the expression of proliferating cell nuclear antigen (PCNA), Bax, vimentin, and E-cadherin. The expression of nuclear factor κB (NF-κB) p65 in the EVs was also detected.

Results: Our results showed that the EVs isolated from the Cur-medium weakened RKO cell proliferation and migration but had no effect on cell apoptosis. Cur suppressed the expression of NF-κB p65 in the EVs. Overall, this study revealed that Cur exerts anti-tumor effects by suppressing NF-κB p65 in EVs to weaken RKO cell proliferation and migration.

Conclusions: In conclusion, the packaging of Cur into EVs is expected to become an indispensable treatment of colorectal cancer in the future.

Citing Articles

Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin.

Vlahopoulos S Int J Mol Sci. 2024; 25(16).

PMID: 39201306 PMC: 11354898. DOI: 10.3390/ijms25168621.

References

Guo S, Huang J, Li G, Chen W, Li Z, Lei J . The role of extracellular vesicles in circulating tumor cell-mediated distant metastasis. Mol Cancer. 2023; 22(1):193. PMC: 10688140. DOI: 10.1186/s12943-023-01909-5. View

Leung W, Baxley R, Traband E, Chang Y, Rogers C, Wang L . FANCD2-dependent mitotic DNA synthesis relies on PCNA K164 ubiquitination. Cell Rep. 2023; 42(12):113523. PMC: 10842461. DOI: 10.1016/j.celrep.2023.113523. View

Liu C, Rokavec M, Huang Z, Hermeking H . Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis. Cell Death Differ. 2023; 30(7):1771-1785. PMC: 10307888. DOI: 10.1038/s41418-023-01178-1. View

Liu G, Chen J, Bao Z . Promising antitumor effects of the curcumin analog DMC-BH on colorectal cancer cells. Aging (Albany NY). 2023; 15(6):2221-2236. PMC: 10085616. DOI: 10.18632/aging.204610. View

Yu C, Chen T, Lu S, Hu W, Zhang Q, Tan J . Identification of Significant Modules and Targets of Xian-Lian-Jie-Du Decoction Based on the Analysis of Transcriptomics, Proteomics and Single-Cell Transcriptomics in Colorectal Tumor. J Inflamm Res. 2022; 15:1483-1499. PMC: 8898059. DOI: 10.2147/JIR.S344861. View

Diaz Osterman C, Lynch J, Leaf P, Gonda A, Ferguson Bennit H, Griffiths D . Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function. PLoS One. 2015; 10(7):e0132845. PMC: 4503627. DOI: 10.1371/journal.pone.0132845. View

Yue M, Hu S, Sun H, Tuo B, Jia B, Chen C . Extracellular vesicles remodel tumor environment for cancer immunotherapy. Mol Cancer. 2023; 22(1):203. PMC: 10717809. DOI: 10.1186/s12943-023-01898-5. View

Xia F, Xie M, He J, Cheng D . Circ_0004140 promotes lung adenocarcinoma progression by upregulating NOVA2 via sponging miR-330-5p. Thorac Cancer. 2023; 14(35):3483-3494. PMC: 10719663. DOI: 10.1111/1759-7714.15141. View

Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa A . NF-κB targeting for overcoming tumor resistance and normal tissues toxicity. J Cell Physiol. 2019; 234(10):17187-17204. DOI: 10.1002/jcp.28504. View

10.

Lu J, Kornmann M, Traub B . Role of Epithelial to Mesenchymal Transition in Colorectal Cancer. Int J Mol Sci. 2023; 24(19). PMC: 10573312. DOI: 10.3390/ijms241914815. View

11.

Li Y, Sun J, Granados-Lopez A, Chu Z, Zhang H . study of miRNA-369-3p targeting TCF4 regulating the malignant biological behavior of colon cancer cells. J Gastrointest Oncol. 2023; 14(5):2124-2133. PMC: 10643592. DOI: 10.21037/jgo-23-628. View

12.

Abd El-Hack M, El-Saadony M, Swelum A, Arif M, Abo Ghanima M, Shukry M . Curcumin, the active substance of turmeric: its effects on health and ways to improve its bioavailability. J Sci Food Agric. 2021; 101(14):5747-5762. DOI: 10.1002/jsfa.11372. View

13.

Lu Y, Godbout K, Lamothe G, Tremblay J . CRISPR-Cas9 delivery strategies with engineered extracellular vesicles. Mol Ther Nucleic Acids. 2023; 34:102040. PMC: 10571031. DOI: 10.1016/j.omtn.2023.102040. View

14.

Song L, Wang J, Gong M, Duan Y, Zhang Y, Li Y . Investigation of the principle of concoction by using the processing excipient Glycyrrhiza uralensis Fisch. juice to reduce the main toxicity of Dioscorea bulbifera L. and enhance its main efficacy as expectorant and cough suppressant. J Ethnopharmacol. 2023; 319(Pt 3):117372. DOI: 10.1016/j.jep.2023.117372. View

15.

Tong Q, Wu Z . Curcumin inhibits colon cancer malignant progression and promotes T cell killing by regulating miR-206 expression. Clin Anat. 2023; 37(1):2-11. DOI: 10.1002/ca.24057. View

16.

Chen J, Zhao L, Xu M, Huang D, Sun X, Zhang Y . Novel isobavachalcone derivatives induce apoptosis and necroptosis in human non-small cell lung cancer H1975 cells. J Enzyme Inhib Med Chem. 2023; 39(1):2292006. PMC: 11721617. DOI: 10.1080/14756366.2023.2292006. View

17.

Chen J, Wu S, Shi Z, Hu B . Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action. Chin Med. 2023; 18(1):14. PMC: 9923939. DOI: 10.1186/s13020-023-00719-7. View

18.

Jalilian E, Abolhasani-Zadeh F, Afgar A, Samoudi A, Zeinalynezhad H, Langroudi L . Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy. Sci Rep. 2023; 13(1):20770. PMC: 10679154. DOI: 10.1038/s41598-023-48073-w. View

19.

Yu Z, Bai X, Zhou R, Ruan G, Guo M, Han W . Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019. Int J Cancer. 2023; 154(4):615-625. DOI: 10.1002/ijc.34740. View

20.

Schluter C, Duchrow M, Wohlenberg C, BECKER M, Key G, Flad H . The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol. 1993; 123(3):513-22. PMC: 2200129. DOI: 10.1083/jcb.123.3.513. View